Australian Clinical Labs Ltd
ASX:ACL

Watchlist Manager
Australian Clinical Labs Ltd Logo
Australian Clinical Labs Ltd
ASX:ACL
Watchlist
Price: 2.76 AUD Market Closed
Market Cap: 545.7m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ACL stock under the Base Case scenario is 7.5 AUD. Compared to the current market price of 2.76 AUD, Australian Clinical Labs Ltd is Undervalued by 63%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ACL Relative Value
Base Case
7.5 AUD
Undervaluation 63%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
75
vs Industry
69
Median 3Y
0.8
Median 5Y
0.9
Industry
2.3
Forward
0.7
More Details
17.9
P/E
P/E
Price to Earnings
17.9
vs History
40
vs Industry
28
Median 3Y
18.5
Median 5Y
13.7
Industry
22
Forward
15.5
More Details
3.3
P/OCF
P/OCF
Price to OCF
3.3
vs History
75
vs Industry
51
Median 3Y
3.7
Median 5Y
3.8
Industry
14.3
More Details
17.5
P/FCFE
P/FCFE
Price to FCFE
17.5
vs History
17
vs Industry
24
Median 3Y
9.6
Median 5Y
8.4
Industry
20
More Details
3.3
P/B
P/B
Price to Book Value
3.3
vs History
75
vs Industry
24
Median 3Y
3.5
Median 5Y
3.6
Industry
2.2
More Details
1
EV/S
EV/S
Enterprise Value to Sales
1
vs History
76
vs Industry
65
Median 3Y
1.1
Median 5Y
1.1
Industry
2.4
Forward
1
More Details
1.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.2
vs History
80
vs Industry
77
Median 3Y
1.3
Median 5Y
1.4
Industry
5
More Details
10.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.9
vs History
48
vs Industry
29
Median 3Y
11.8
Median 5Y
9.3
Industry
11.6
Forward
3.5
More Details
10.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.9
vs History
48
vs Industry
35
Median 3Y
11.8
Median 5Y
9.3
Industry
15.9
Forward
10.6
More Details
4.4
EV/OCF
EV/OCF
Enterprise Value to OCF
4.4
vs History
75
vs Industry
49
Median 3Y
4.8
Median 5Y
4.9
Industry
14.3
More Details
4.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
4.6
vs History
75
vs Industry
41
Median 3Y
5.1
Median 5Y
5.2
Industry
18
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
84
vs Industry
45
Median 3Y
1.5
Median 5Y
1.6
Industry
1.8
More Details

Multiples Across Competitors

ACL Competitors Multiples
Australian Clinical Labs Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Australian Clinical Labs Ltd
ASX:ACL
549.6m AUD 0.8 17.9 10.9 10.9
US
Cigna Group
XMUN:CGN
71.5B EUR 0.3 16.6 8.2 10.5
US
Cigna Corp
NYSE:CI
81.9B USD 0.3 16.3 8.1 10.4
US
CVS Health Corp
NYSE:CVS
81.8B USD 0.2 15.5 12.8 12.8
DE
Fresenius Medical Care AG
XMUN:FME
27.5B EUR 1.4 44.5 11.8 25.5
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.6B EUR 1.1 56 10.3 16.6
US
Laboratory Corporation of America Holdings
NYSE:LH
20.9B USD 1.6 28.6 14.5 22.9
US
Quest Diagnostics Inc
NYSE:DGX
18.8B USD 1.9 21.1 12.4 16.8
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.8B EUR 0.7 22.3 7.2 15.7
US
Hims & Hers Health Inc
NYSE:HIMS
10.7B USD 6 65.1 75.3 89.9
US
DaVita Inc
NYSE:DVA
11.1B USD 0.8 12.8 7.6 10.3

See Also

Summary
ACL intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACL stock valuation using valuation multiples.
Wall Street Estimates
ACL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 267,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.